149 results on '"Emdad, Luni"'
Search Results
2. Pharmacological inhibition of MDA-9/Syntenin blocks breast cancer metastasis through suppression of IL-1β
3. Noninvasive therapy of brain cancer using a unique systemic delivery methodology with a cancer terminator virus.
4. SARI inhibits growth and reduces survival of oral squamous cell carcinomas (OSCC) by inducing endoplasmic reticulum stress
5. Lumefantrine, an antimalarial drug, reverses radiation and temozolomide resistance in glioblastoma
6. Identification of Annexin A2 as a key mTOR target to induce roller coaster pattern of autophagy fluctuation in stress
7. MDA-7/IL-24 regulates the miRNA processing enzyme DICER through downregulation of MITF
8. REPLY TO YOSHIDA : Delineating critical roles of MDA-9 in protective autophagy-mediated anoikis resistance in human glioma stem cells
9. MDA-9/Syntenin regulates protective autophagy in anoikis-resistant glioma stem cells
10. Regulation of neuroblastoma migration, invasion, and in vivo metastasis by genetic and pharmacological manipulation of MDA-9/Syntenin
11. Targeting Gene Expression Selectively in Cancer Cells by Using the Progression-Elevated Gene-3 Promoter
12. Inhibition of radiation-induced glioblastoma invasion by genetic and pharmacological targeting of MDA-9/Syntenin
13. Somatostatin receptor targeted liposomes with Diacerein inhibit IL-6 for breast cancer therapy
14. MDA-9/Syntenin in the tumor and microenvironment defines prostate cancer bone metastasis.
15. Astrocyte Elevated Gene-1 (AEG-1) Regulates Lipid Homeostasis
16. Transcription factor Late SV40 Factor (LSF) functions as an oncogene in hepatocellular carcinoma
17. Astrocyte Elevated Gene-1 (AEG-1) Functions as an Oncogene and Regulates Angiogenesis
18. Cloning and Characterization of SARI (Suppressor of AP-1, Regulated by IFN)
19. Astrocyte Elevated Gene-1 (AEG-1) Is a Target Gene of Oncogenic Ha-ras Requiring Phosphatidylinositol 3-Kinase and c-Myc
20. Characterization of fenofibrate-mediated anti-proliferative pro-apoptotic effects on high-grade gliomas and anti-invasive effects on glioma stem cells
21. mda-7/IL-24: A unique member of the IL-10 gene family promoting cancer-targeted toxicity
22. Noninvasive approaches for detecting and monitoring bladder cancer
23. Expression patterns of MDA-9/syntenin during development of the mouse embryo
24. Astrocyte elevated gene-1 regulates hepatocellular carcinoma development and progression
25. Unique aspects of mda-7/IL-24 antitumor bystander activity: establishing a role for secretion of MDA-7/IL-24 protein by normal cells
26. Potential molecular mechanism for rodent tumorigenesis: mutational generation of Progression Elevated Gene-3 (PEG-3)
27. Astrocyte elevated gene-1 promotes hepatocarcinogenesis: Novel insights from a mouse model
28. Enhanced Cancer Therapy Using an Engineered Designer Cytokine Alone and in Combination With an Immune Checkpoint Inhibitor.
29. Conversion of a Non-Cancer-Selective Promoter into a Cancer-Selective Promoter.
30. Increased RNA-induced silencing complex (RISC) activity contributes to hepatocellular carcinoma
31. Astrocyte elevated gene-1 (AEG-1): A multifunctional regulator of normal and abnormal physiology
32. The development of MDA-7/IL-24 as a cancer therapeutic
33. GAP junctions: multifaceted regulators of neuronal differentiation.
34. The quest to develop an effective therapy for neuroblastoma.
35. Melanoma differentiation associated gene-7/interleukin-24 (mda-7/IL-24): Novel gene therapeutic for metastatic melanoma
36. Astrocyte elevated gene-1: Recent insights into a novel gene involved in tumor progression, metastasis and neurodegeneration
37. mda-7/IL-24: Multifunctional cancer-specific apoptosis-inducing cytokine
38. Recent insights into apoptosis and toxic autophagy: The roles of MDA-7/IL-24, a multidimensional anti-cancer therapeutic.
39. MDA-9/Syntenin/SDCBP: new insights into a unique multifunctional scaffold protein.
40. Cancer terminator viruses (<italic>CTV</italic>): A better solution for viral‐based therapy of cancer.
41. HIV induces expression of complement component C3 in astrocytes by NF-κB-dependent activation of interleukin-6 synthesis.
42. Rethinking Glioblastoma Therapy: MDA-9/Syntenin Targeted Small Molecule.
43. Suppression of miR-184 in malignant gliomas upregulates SND1 and promotes tumor aggressiveness.
44. Role of the staphylococcal nuclease and tudor domain containing 1 in oncogenesis (Review).
45. Gene Therapies for Cancer: Strategies, Challenges and Successes.
46. Sequential release of drugs from hollow manganese ferrite nanocarriers for breast cancer therapy[†].
47. Astrocyte Elevated Gene-1 Interacts with Akt Isoform 2 to Control Glioma Growth, Survival, and Pathogenesis.
48. Staphylococcal nuclease domain containing-1 (SND1) promotes migration and invasion via angiotensin II type 1 receptor (AT1R) and TGFβ signaling.
49. Analysis of Global Changes in Gene Expression Induced by Human Polynucleotide Phosphorylase ( hPNPaseold-35).
50. MDA-9/syntenin is a key regulator of glioma pathogenesis.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.